According to a new report from Intel Market Research, the global Anti-Idiotypic Antibody Development Service market was valued at USD 161 million in 2024 and is projected to reach USD 274 million by 2032, growing at a steady CAGR of 8.0% during the forecast period (2025–2032). This expansion reflects the biotechnology sector's accelerating demand for customized immunotherapies and...